首页> 外文期刊>Current oncology >Superficial parotid lobe–sparing delineation approach: a better method of dose optimization to protect the parotid gland in intensity-modulated radiotherapy for nasopharyngeal carcinoma
【24h】

Superficial parotid lobe–sparing delineation approach: a better method of dose optimization to protect the parotid gland in intensity-modulated radiotherapy for nasopharyngeal carcinoma

机译:腮腺浅叶保留勾画方法:鼻咽癌调强放射治疗中保护腮腺的最佳剂量优化方法

获取原文
           

摘要

Purpose We used a superficial parotid lobe–sparing delineation approach for dose optimization with better protection for the parotid glands in intensity-modulated radiotherapy (imrt) for nasopharyngeal carcinoma (npc) patients. Methods Compared with traditional contouring of the entire parotid glands as organs at risk (oars) in imrt for npc, we used a superficial parotid lobe–sparing delineation approach of contouring the superficial parotid lobes as oars. Changes in dose to the parotid glands, the targets, and other oars were evaluated. Results The mean dose to the parotid glands overall decreased by more than 4 Gy in the test plans. Impressively, the mean dose to the superficial parotid lobes in the test plans was not more than 30 Gy, regardless of clinical stage. In T1–3 npc patients, the dose distributions for targets were not significantly different in the control plans and the test plans. However, for some T4 patients, the dose distributions for targets and brainstem in the test plans could not meet clinical requirements. Conclusions The superficial parotid lobe–sparing delineation approach can significantly lower the mean dose tothe entire parotid and to the superficial parotid lobe in T1–3 npc patients, which would be expected to result in less xerostomia and better quality of life for those patients.
机译:目的我们采用了浅表腮腺保留划界方法来优化剂量,并在鼻咽癌(npc)患者的调强放射治疗(imrt)中更好地保​​护了腮腺。方法与传统的将腮腺作为ipc的高危器官(桨)等高线对整个腮腺轮廓进行轮廓绘制相比,我们采用了腮腺浅叶-轮廓勾画方法将腮腺浅叶作为轮廓进行轮廓勾画。评估腮腺,靶标和其他桨的剂量变化。结果在测试计划中,腮腺的平均剂量总体下降了4 Gy以上。令人印象深刻的是,无论临床阶段如何,测试计划中腮腺浅叶的平均剂量均不超过30 Gy。在T1–3 npc患者中,对照计划和测试计划中靶标的剂量分布没有显着差异。但是,对于某些T4患者,测试计划中靶标和脑干的剂量分布无法满足临床要求。结论T1–3 npc患者的腮腺浅表保留方法可以显着降低整个腮腺和腮腺的平均剂量,这有望减少这些患者的口腔干燥和生活质量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号